Pfizer updates safety information in the labeling for Exubera
This is a discussion on Pfizer updates safety information in the labeling for Exubera within the FDA News forum, part of the Industry News and Updates category; Pfizer informs healthcare professionals and patients of updated safety information in the labeling for Exubera, a short-acting insulin More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-10-2008, 12:39 PM
|
|||
|
|||
Pfizer updates safety information in the labeling for Exubera
Pfizer informs healthcare professionals and patients of updated safety information in the labeling for Exubera, a short-acting insulin
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA updates safety information for long acting beta agonists (LABA). | industry_news | FDA News | 0 | 03-05-2008 04:10 PM |
| Pediatric Exclusivity Labeling Changes | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |